It is done! - As per our last RA news update, the proposal for the MDR postponement was accepted by the parliament and the amending regulation (EU) 2020/561 was even published already in the Official Journal of the European Union today!
The European commission has published four additional MDCG Guidance documents on 24th of April 2020. Even if the EU MDR might be postponed these Guidance shall be considered by the legal manufacturers immediately.
Also look out for a more detailed analysis of the new guidance in the upcoming week…
The EU commission service has published a working document for Current performance of COVID-19 test methods and devices and proposed performance criteria.
Additionally, the annex I Commercial devices: provides an overview of approved test Kits as well an overview of the regulatory status.
Several Countries in the APAC Region are still working on an Emergency Use Authorization (EUA) for Products during the COVID-19 pandemic.
List of COVID-19 related EUA on Manufacturing / Import of Medical Device.
Saudi FDA Regulatory requirements for Emergency Use Authorization (EUA) for IVDD and Personal Protective Equipment (PPE) during the outbreak of COVID-19.
1. NMPA gives emergency approvals to COVID-19 test kits.
2. Regulatory Requirements and Standards for Coronavirus Reagent Test Kits and Protective Equipment in China.
List of COVID-19 Diagnostic Kits Authorized for Use under Emergency Use Authorizations.
The International Medical Devices Regulatory Forum (IMDRF) has published 4 new documents on 20th of April 2020.
This document provides concrete recommendations to all responsible stakeholders on the general principles and best practices for medical device cybersecurity (including in vitro diagnostic (IVD) medical devices) and Employ a risk-based approach to the design and development of medical devices with appropriate cybersecurity protections.
It shall Ensure the safety, performance, and security of medical devices and the connected healthcare infrastructure during the total Product life Cycle (TPLC) and differentiate between Pre-Market Considerations for Medical Device Cybersecurity and Post-Market Considerations for Medical Device Cybersecurity in respect to
Terminologies for Categorized Adverse Event Reporting (AER): terms, terminology and codes - PDF (1.21Mb)
You can download all Regulatory Affairs Updates compiled for you as a PDF under the following link.